Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

Autor:	Francesca Cottini, Gullu Gorgun, YT Tai, P. G. Richardson, Diana Cirstea, Kenneth C. Anderson, Teruhiro Utsugi, Rikio Suzuki, Jiro Minami, Naoya Mimura, Teru Hideshima, Yasuhiro Yoshida, D Chauhan, Shohei Kikuchi, Jana Jakubikova, NC Munshi, Hiroto Ohguchi
Rok vydání:	2014
Předmět:	Cancer Research animal structures Cell Survival HSP90 Heat-Shock Proteins Antineoplastic Agents Apoptosis Mice SCID Retinal Pigment Epithelium Biology Article Cell Line Bortezomib Mice immune system diseases Monomeric GTP-Binding Proteins hemic and lymphatic diseases Cell Line Tumor Antineoplastic Combined Chemotherapy Protocols medicine Animals Humans Multiple myeloma Cell Proliferation Antitumor activity Cell growth Hematology medicine.disease Molecular biology Boronic Acids Oncology Cell culture Pyrazines Benzamides Mutation Cancer research Pyrazoles Drug Screening Assays Antitumor Multiple Myeloma Neoplasm Transplantation medicine.drug
Zdroj:	Leukemia
ISSN:	1476-5551
Popis:	Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0fa83f782eeacf3b7924d71225032fe https://pubmed.ncbi.nlm.nih.gov/25306900 Zobrazit plný text záznamu